Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats
Yanfang Zhang(East China Normal University), Xin Wang(Guangdong Pharmaceutical University), Bingyi Yao(Shanghai Changning Maternity and Infant Health Hospital), Chenmeizi Liang(Shanghai Changning Maternity and Infant Health Hospital), Jie Liu(Hubei University of Medicine), Junze Huang(Shanghai Changning Maternity and Infant Health Hospital), Yuanqing Guo(Fifth Affiliated Hospital of Sun Yat-sen University), Yu Tang(Nanjing University of Chinese Medicine), Yuanjin Zhang(Shanghai Changning Maternity and Infant Health Hospital), Shengbo Huang(Tianjin Hospital)
Cited by 8
Related Papers
Progress, challenges, and future of nanomedicine
|Nano Today|2020|306
A minimalist fluorescent probe for differentiating Cys, Hcy and GSH in live cells
|Chemical Science|2015|215
Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine
|Scientific Reports|2016|78
Systemic regulation of L-carnitine in nutritional metabolism in zebrafish, Danio rerio
|Scientific Reports|2017|77
Bioceramic Scaffolds with Antioxidative Functions for ROS Scavenging and Osteochondral Regeneration
|Advanced Science|2022|68